Rachelle Crescenzi1, Paula M.C. Donahue2,3, Kalen J Petersen1, Maria Garza1, Kelsey Guerreso1, Yu Luo1, Joshua A. Beckman4, and Manus J. Donahue1,5,6
1Radiology, Vanderbilt University Medical Center, Nashville, TN, United States, 2Dayani Center for Health and Wellness, Vanderbilt University Medical Center, Nashville, TN, United States, 3Physical Medicine and Rehabilitation, Vanderbilt University Medical Center, Nashville, TN, United States, 4Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN, United States, 5Neurology, Vanderbilt University Medical Center, Nashville, TN, United States, 6Psychiatry, Vanderbilt University Medical Center, Nashville, TN, United States
Synopsis
The
lymphatic system comprises a central component of the circulatory system, yet
imaging approaches to visualize lymphatics remain underdeveloped. We utilized
MR lymphangiography and sodium MRI to confirm lymphatic impairment in patients
with lymphedema of known causes, and in patients with the adipose disorder lipedema
of unknown etiology. We report distinct profiles on MR lymphangiography that
correlate with tissue sodium and fat deposition. Results provide evidence of lymphatic
involvement in lipedema that informs disease mechanisms related to swelling,
and more broadly relates to lymphatic clearance dysfunction in a range of
diseases where sodium and fat are implicated.
Introduction
The
lymphatic system comprises a central component of the human circulatory system,
functioning in immune surveillance(1), blood-pressure
control(2,3), and clearance of macromolecules
and tissue sodium(4). Lymphatic impairment plays
a role in cancer metastasis(5), cancer treatment comorbidities
including lymphedema(6), and adipose disorders(7). Yet imaging approaches to visualize lymphatics and study
disease mechanisms remain substantially underdeveloped relative to their blood
counterparts. Recently, MRI relaxation times were measured in human lymphoid
tissue(8) and lymphatic fluid(9). These measurements enabled
parameterization of long turbo-spin-echo (TSE) approaches for imaging lymphatic
vasculature(10,11) which show contrast
consistent with lymphatic impairment in patients with secondary lymphedema of
known origin. These approaches provide a foundation for performing non-invasive
MR lymphangiography, yet their applications are only beginning to be
evaluated.
The
goal of this work was to develop a radiologic scoring system for MR
lymphangiography based upon contrast in a lymphatic disease of know origin, secondary
lymphedema following lymph node removal for cancer therapy. Then, we applied
this scoring system in patients with the adipose disorder lipedema, in which
lymphatic involvement is suspected given clinical evidence of swelling and MRI
measurement of sodium and fat in the legs(12). We hypothesized that (i)
a radiological score for MR lymphangiography can differentiate varying degrees
of lymphatic impairment in patients with lymphedema, lipedema, or healthy controls,
and (ii) a positive relationship exists between lymphangiography contrast and tissue
sodium and fat content.Methods
Participants (n=32)
provided informed consent. Enrolled participants met clinical criteria for
lipedema (n=22), or secondary leg lymphedema (n=6) following inguinal or pelvic
lymph node removal during cancer therapy. Controls were matched for BMI, race,
and sex (n=14).
MRI acquisition. Multi-nuclear 23Na/1H
MRI of the legs was performed at 3.0T (Philips Ingenia D-Stream, Philips Healthcare,
Best, The Netherlands, Figure 1).
Proton 1H
imaging was used to acquire non-tracer-based MR lymphangiography in the lower
extremities bilaterally with a 16-channel anterior coil (3D
TSE, TR/TE=3000/600 ms, TSE-factor=90, field-of-view=445x241x180 mm3,
spatial resolution=1.39 x 1.39 x 3 mm3, refocusing angle=110°, 60 mm thick rest slabs placed 20 mm inferior and superior to
imaging FOV, averages=2, duration=10min 51s).
Sodium 23Na imaging
was acquired in the dominant or affected limbs with a quadrature
single-tuned knee coil (Rapid Biomedical GmbH,
Rimpar, Germany) following published methods (TR/TE=130/0.99
ms; FOV=192x192 mm2, in-plane spatial
resolution=3x3 mm2; slice thickness=30 mm; flip angle=90°; scan
duration=15 min 54 s). Four aqueous sodium
standards containing physiologic concentrations of NaCl (10, 20, 30, and 40
mmol/L) were embedded in the FOV and used for signal calibration.
In an identical FOV as
sodium imaging, multi-point Dixon imaging was acquired using the body coil (TR=200 ms,
TE1=1.15 ms, TE2=2.30 ms; in-plane spatial resolution=1x1 mm2;
slice thickness=5 mm; flip angle=90°, scan duration=4 min).
Lymphangiography analysis. MR lymphangiography
images were independently evaluated in a blinded review by two board-certified
radiologists with musculoskeletal subspecialty training. On the transverse
view, the appearance of hyperintensities was graded as either localized,
diffuse, or not apparent in (i) muscular, (ii) subcutaneous, and (iii)
interface between musclar and subcutaneous compartments (i.e. peri-muscular).
On the maximum-intensity-projection (MIP) view, the appearance of vascular
structures (hyperintensities continuous between slices) were graded as either
dilated/ectatic/tortuous, linear and consistent in caliber, or not apparent in
each compartment (i-iii). In total, 15 features were scored as either present
(1) or absent (0), and the frequency calculated. The most frequent features
were combined in a weighted summation (Table 1) to calculate a
lymphangiography score (0-9).
Fat and sodium analysis. Tissue sodium content (TSC)
maps were calculated from a linear calibration in the sodium standards. The
skin was segmented on the Dixon water-weighted image and applied to the sodium
map to calculate mean TSC (mmol/L). Fat-fraction (ratio) of fat and non-fat
soft tissue areas (muscle+skin) was computed from the Dixon fat-weighted and
water-weighted images of the calf.
Statistical
analysis.
Group
differences in imaging metrics were evaluated using a one-way ANOVA with
significance criteria p<0.05. A logistic regression model of the
radiological score was evaluated, using independent variables of TSC, fat-fraction,
and age (32 observations, 28 degrees of freedom, significance criteria
p<0.05). Results
Patients with lymphedema and lipedema display distinct profiles of image contrast on MR lymphangiography and multi-nuclear imaging (Figure 1). Radiological scoring of MR
lymphangiography revealed the most frequent (>40%) features of
hyperintensities according to group (Table 1). Quantitative
analyses revealed significantly different lymphangiography scores, TSC, and fat-fraction
between groups (Table 2). The lymphangiography score can be modeled (model
p=0.04) as a linear function of TSC (β=0.15, p=0.02) and fat-fraction (β=1.6, p=0.04),
with age as a co-variate (β=-0.03, p=0.33). Discussion
We
report a radiological scoring system for lymphatic impairment based on noninvasive
MR lymphangiography contrast, which is highest in patients with lymphedema, and
differential in patients with lipedema compared to healthy controls. This
finding indicates lymphatic involvement in the setting of lipedema. Further,
the severity of impairment visualized on MR lymphangiography is associated with
quantitative metrics of tissue sodium and fat deposition in patients with
lower-extremity swelling. Conclusion
Noninvasive
MR lymphangiography and sodium MRI have potential to provide imaging tools
for further assessing lymphatic impairment and clearance dysfunction in a range
of comorbidities where tissue sodium and fat are known to accumulate. Acknowledgements
Imaging
experiments were performed in the Vanderbilt Human Imaging Core, using research
resources supported by the National Institutes of Health (NIH) grant 1S10OD021771-01. We are grateful to Charles Nockowski, Christopher Thompson,
Leslie McIntosh, and Clair Jones for experimental support. Recruitment through
www.ResearchMatch.org is supported by the National Center for Advancing Translational Sciences (NCATS)
Clinical Translational
Science Award (CTSA) Program, award number 5UL1TR002243-03. Funding was provided by the Lipedema Foundation (LF)
Postdoctoral Research Fellowship, LF Collaborative Grant #12, the NIH/NINR
1R01NR015079, and the Institutional National Research Service Award (NRSA) T32 EB001628. The content is solely the responsibility of the
authors and does not necessarily represent the official views of the NIH.References
1 Tawakol,
A. et al. Association of Arterial and
Lymph Node Inflammation With Distinct Inflammatory Pathways in Human
Immunodeficiency Virus Infection. JAMA
Cardiol 2, 163-171,
doi:10.1001/jamacardio.2016.4728 (2017).
2 Wiig,
H. et al. Immune cells control skin
lymphatic electrolyte homeostasis and blood pressure. J Clin Invest 123,
2803-2815, doi:10.1172/JCI60113 (2013).
3 Johnson,
R. S., Titze, J. & Weller, R. Cutaneous control of blood pressure. Curr Opin Nephrol Hypertens 25, 11-15,
doi:10.1097/MNH.0000000000000188 (2016).
4 Machnik,
A. et al. Mononuclear phagocyte
system depletion blocks interstitial tonicity-responsive enhancer binding
protein/vascular endothelial growth factor C expression and induces
salt-sensitive hypertension in rats. Hypertension
55, 755-761, doi:10.1161/HYPERTENSIONAHA.109.143339
(2010).
5 Karaman,
S. & Detmar, M. Mechanisms of lymphatic metastasis. J Clin Invest 124,
922-928, doi:10.1172/JCI71606 (2014).
6 Rockson,
S. G. Lymphedema after Breast Cancer Treatment. N Engl J Med 380, 694,
doi:10.1056/NEJMc1817537 (2019).
7 Hoffner,
M., Peterson, P., Mansson, S. & Brorson, H. Lymphedema Leads to Fat
Deposition in Muscle and Decreased Muscle/Water Volume After Liposuction: A
Magnetic Resonance Imaging Study. Lymphat
Res Biol 16, 174-181,
doi:10.1089/lrb.2017.0042 (2018).
8 Crescenzi,
R. et al. 3.0 T relaxation time
measurements of human lymph nodes in adults with and without lymphatic
insufficiency: Implications for magnetic resonance lymphatic imaging. NMR Biomed 31, e4009, doi:10.1002/nbm.4009 (2018).
9 Rane,
S. et al. Clinical feasibility of
noninvasive visualization of lymphatic flow with principles of spin labeling MR
imaging: implications for lymphedema assessment. Radiology 269, 893-902,
doi:10.1148/radiol.13120145 (2013).
10 Crescenzi,
R. et al. Lymphedema evaluation using
noninvasive 3T MR lymphangiography. J
Magn Reson Imaging 46,
1349-1360, doi:10.1002/jmri.25670 (2017).
11 Arrive,
L. et al. Primary lower limb
lymphoedema: classification with non-contrast MR lymphography. Eur Radiol,
doi:10.1007/s00330-017-4948-z (2017).
12 Crescenzi,
R. et al. Tissue Sodium Content is
Elevated in the Skin and Subcutaneous Adipose Tissue in Women with Lipedema. Obesity (Silver Spring) 26, 310-317, doi:10.1002/oby.22090
(2018).